Max Hodak
Chief Executive Officer
Science Corporation is a clinical-stage medical technology company
With dozens of patients in six countries enrolled in our ongoing clinical studies, we are committed to translating innovations from bench to bedside for the benefit of everyone.
We work to restore quality of life to those with debilitating conditions for which there are no treatment options, creating devices aimed at restoring vision, cognition, and mobility to patients who have lost it. To support progress across our industry, we provide state-of-the-art components and vertically integrated infrastructure for others to build on via Science Foundry.
Headquartered in Alameda, California, we are a global company with secondary offices in Research Triangle Park, North Carolina and Paris, France.
Leadership
Our leadership team brings decades of experience in neural engineering, neuroscience research, and building breakthrough technology companies.
-
-
Alan Mardinly, PhD
Chief Scientific Officer
-
Emma Zhou
Director of BCI Research
-
Aaron Bartnick
Chief of Staff
-
Alex Feerst, PhD
Chief Legal Officer
-
Darius Shahida
Chief Strategy Officer
-
Davin Hsieh
VP of Finance
-
Frank Brodie, MD
Medical Director for Vision & PRIMA
-
Joe Mornin
General Counsel
-
Kylie Alsofrom
Director of Operations
-
Marcus Simon
Director of Market Access
-
Ralf Hornig, PhD
Director of Clinical Affairs
-
Richard Socarides
Senior Advisor
Our Values
-
Patients First
We believe that all patients should have agency over their lives and that patient needs must be prioritized, especially the right to privacy.
We believe that patient desires must be respected and prioritized in treatment. We want to make sure all patients have fair and equal access to care and innovation.
-
Responsible for the Common Good
We are committed to setting high ethical standards for our industry. We recognize that our work is new and must be explained and understood.
We will work with governments, civil society, and other leading companies (including competitors) to define and set rules and regulations for our industry. We are scientists and engineers deeply committed to working for the common good, responsibly and safely, with care and compassion for all living things and for our planet.
-
Modern Pioneers
We are modern pioneers set on pursuing new frontiers of medicine, science, and technology to advance human well-being.
We believe that neurotechnology is on the cusp of important breakthroughs that will significantly improve human life. We are determined to help lead that effort, and to ensure patients have the best and most complete access possible to innovative technologies that address their condition.
-
Following Science Where it Leads
We hire the smartest people we can find and rely on their good judgment.
We value the different backgrounds, experiences and outlooks which exist on our team, believing it will achieve the best results — especially with strong teamwork and collaboration. We believe the simplest way to do something is always the best first option. Our start-up culture embraces new ideas, and we don't worry about moving on when an idea does not pan out.
Our Work & Approach
Science Corporation is a leader in the field of brain-computer interface (BCI) technology, and the emerging field of neural engineering more broadly. We are driven by the conviction that everyone deserves control over their lives, and we prioritize patient rights, especially the right to privacy, in all we do.
Vertical Integration
We have significant in-house capabilities ranging from fabricating transistors to high-throughput cell editing to complex animal behavior, all integrated into one Science team. Our multidisciplinary approach enables us to push boundaries others have to simply accept.
Commitment to Our Patients
We recognize our work is new and needs to be thoroughly explained and understood. We believe that neurotechnology is on the cusp of important breakthroughs that will significantly improve human life. We are determined to help lead that effort, and to make sure patients have the best and most complete access possible.
Science for Patients
